Denali Therapeutics Inc.   Report issue

For profit Phase 1 Phase 2
Founded: San Francisco CA United States (2015)

Organization Overview

First Clinical Trial
2017
NCT04551534
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Denali Therapeutics | Denali Therapeutics Inc.